BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10567690)

  • 1. Hepoxilins raise circulating insulin levels in vivo.
    Pace-Asciak CR; Demin PM; Estrada M; Liu G
    FEBS Lett; 1999 Nov; 461(3):165-8. PubMed ID: 10567690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepoxilins sensitize blood vessels to noradrenaline--stereospecificity of action.
    Laneuville O; Couture R; Pace-Asciak CR
    Br J Pharmacol; 1992 Feb; 105(2):297-304. PubMed ID: 1559126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure, biochemistry and biology of hepoxilins: an update.
    Nigam S; Zafiriou MP; Deva R; Ciccoli R; Roux-Van der Merwe R
    FEBS J; 2007 Jul; 274(14):3503-3512. PubMed ID: 17608719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepoxilins, potential endogenous mediators of insulin release.
    Pace-Asciak CR; Martin JM; Corey EJ
    Prog Lipid Res; 1986; 25(1-4):625-8. PubMed ID: 3321096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous release of hepoxilin A3 from isolated perifused pancreatic islets of Langerhans.
    Pace-Asciak CR; Martin JM; Corey EJ; Su WG
    Biochem Biophys Res Commun; 1985 Apr; 128(2):942-6. PubMed ID: 3888220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepoxilin, a new family of insulin secretagogues formed by intact rat pancreatic islets.
    Pace-Asciak CR; Martin JM
    Prostaglandins Leukot Med; 1984 Nov; 16(2):173-80. PubMed ID: 6396652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of the hepoxilins.
    Pace-Asciak CR
    Biochim Biophys Acta; 2015 Apr; 1851(4):383-96. PubMed ID: 25240838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation and electrophysiological actions of the arachidonic acid metabolites, hepoxilins, at nanomolar concentrations in rat hippocampal slices.
    Carlen PL; Gurevich N; Zhang L; Wu PH; Reynaud D; Pace-Asciak CR
    Neuroscience; 1994 Feb; 58(3):493-502. PubMed ID: 7909586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepoxilins: a review on their cellular actions.
    Pace-Asciak CR
    Biochim Biophys Acta; 1994 Nov; 1215(1-2):1-8. PubMed ID: 7947989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurokinin A-induced contraction of guinea-pig isolated trachea: potentiation by hepoxilins.
    Laneuville O; Couture R; Pace-Asciak CR
    Br J Pharmacol; 1992 Nov; 107(3):808-12. PubMed ID: 1335339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepoxilins. A review.
    Pace-Asciak CR; Reynaud D; Demin P; Nigam S
    Adv Exp Med Biol; 1999; 447():123-32. PubMed ID: 10086189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of insulinotropic effect of hepoxylins: proof of a direct effect of hepoxylins B3 on insulin secretion not connected with glucose].
    Fedotov VP; Sadovnikova NV; Baranova IN; Vasil'eva LL; Manukina TA; Pivnitskiĭ KK
    Biull Eksp Biol Med; 1995 Oct; 120(10):404-6. PubMed ID: 8595233
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepoxilin A3 increases vascular permeability in the rat skin.
    Laneuville O; Corey EJ; Couture R; Pace-Asciak CR
    Eicosanoids; 1991; 4(2):95-7. PubMed ID: 1910867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of 14,15-hepoxilins of the A(3) and B(3) series through a 15-lipoxygenase and hydroperoxide isomerase present in garlic roots.
    Reynaud D; Ali M; Demin P; Pace-Asciak CR
    J Biol Chem; 1999 Oct; 274(40):28213-8. PubMed ID: 10497175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and metabolic perturbations in isolated pancreatic islets from the GK rat, a genetic model of noninsulin-dependent diabetes.
    Giroix MH; Vesco L; Portha B
    Endocrinology; 1993 Feb; 132(2):815-22. PubMed ID: 8425496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis of 14,15-hepoxilins in human l1236 Hodgkin lymphoma cells and eosinophils.
    Brunnström A; Hamberg M; Griffiths WJ; Mannervik B; Claesson HE
    Lipids; 2011 Jan; 46(1):69-79. PubMed ID: 21046276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hepoxilins and some analogues: a review of their biology.
    Pace-Asciak CR
    Br J Pharmacol; 2009 Oct; 158(4):972-81. PubMed ID: 19422397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepoxilin A3 inhibits the rise in free intracellular calcium evoked by formyl-methionyl-leucyl-phenylalanine, platelet-activating factor and leukotriene B4.
    Laneuville O; Reynaud D; Grinstein S; Nigam S; Pace-Asciak CR
    Biochem J; 1993 Oct; 295 ( Pt 2)(Pt 2):393-7. PubMed ID: 8240236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of galnon, a non-peptide galanin-receptor agonist, on insulin release from rat pancreatic islets.
    Quynh NT; Islam MS; Florén A; Bartfai T; Langel U; Ostenson CG
    Biochem Biophys Res Commun; 2005 Mar; 328(1):213-20. PubMed ID: 15670772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic formation of hepoxilins A3 and B3.
    Pace-Asciak CR; Reynaud D; Demin P
    Biochem Biophys Res Commun; 1993 Dec; 197(2):869-73. PubMed ID: 8267626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.